Insider Shareholders with Direct Ownership of Outlook Therapeutics, Inc. (OTLK)
This section provides a comprehensive overview of the insiders with direct ownership of Outlook Therapeutics, Inc. (OTLK). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Outlook Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bio Lexis Pte Ltd.
> 10% Shareholder |
0 | 27,982,529 | 22,982,529 $132 Million | 1 |
Apr 21, 2022
Reduced 54.91%
|
| 3,714,286 | 0 | 1,705,438 $9.82 Million | 2 |
Apr 15, 2024
Added 29.52%
|
|
|
Jeff Evanson
CHIEF COMMERCIAL OFFICER |
97,684 | 496,682 | 808,459 $4.66 Million | 8 |
Mar 07, 2024
Added 7.17%
|
|
Terry Dagnon
Chief Operations Officer |
45,201 | 599,600 | 653,058 $3.76 Million | 6 |
Apr 20, 2023
Reduced 44.33%
|
| 450,000 | 0 | 473,117 $2.73 Million | 10 |
Oct 05, 2022
Added 3.2%
|
|
| 58,000 | 0 | 68,000 $391,680 | 3 |
Oct 07, 2022
Added 30.61%
|
|
|
C Russell Trenary Iii
CEO AND PRESIDENT |
54,925 | 0 | 54,925 $316,368 | 3 |
Jun 21, 2022
Added 26.62%
|
|
Lawrence A Kenyon
Chief Financial Officer |
15,000 | 0 | 5,946 $34,248 | 2 |
Sep 26, 2024
Added 45.68%
|
| 55,224 | 0 | 5,048 $29,076 | 5 |
Mar 28, 2024
Added 27.15%
|